Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OFF-LABEL PROMOTIONS, FDA/INDUSTRY COLLABORATION ON DRUG DEVELOPMENT WILL BE SUBJECT OF SENATE HEARING FEB. 21-22; KASSEBAUM BILL MARK-UP EXPECTED IN MARCH

Executive Summary

Off-label promotion of drugs will be the subject of one of two days of hearings scheduled by Sen. Kassebaum's (R-Kan.) Labor & Human Resources Committee Feb. 21-22.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027601

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel